Smoking and mortality risk in COPD patients: a prospective cohort study in Sichuan, China.
Boke Chen, Di Wu, Xiaofang Chen, Xia Wu et al.
Kernaussage
Smoking is an independent risk factor for all-cause, COPD-specific, and CVD mortality in COPD patients in Sichuan, with a dose-response relationship observed for consumption, duration, and age of onset.
Abstract
To assess the association between smoking and mortality in patients with chronic obstructive pulmonary disease (COPD) in Sichuan Province, China. Data concerning COPD patients in Pengzhou, Sichuan was collated from the China Kadoorie Biobank (CKB). COPD was defined as post-bronchodilator forced expiratory volume in 1 s/forced vital capacity of <70%. The relationship between smoking and mortality was evaluated by Cox proportional hazards regression. Eight thousand five hundred one COPD patients, aged 30-79 years, were enrolled enabling analysis of 85,600 person-years of follow-up data (mean follow-up: 10.07 years). Two thousand deaths occurred during the period of investigation, including 665 from COPD and 1,116 from cardiovascular disease (CVD). Ex-smokers were at higher risk of both all-cause mortality [hazard ratio (HR) 1.56; 95% confidence interval (CI) 1.36-1.80], COPD (HR 2.24; 95% CI 1.80-2.80) and CVD mortality (HR 1.54; 95% CI 1.28-1.85) than those who had never smoked. An increased duration of smoking was associated with higher risk of death. A dose-response relationship was observed. Patients who smoked > 20 g tobacco/day had 35% higher all cause, 66% higher COPD and 34% higher CVD mortality risk. Those with cumulative exposures ≥ 250,000 g had the highest risks of all outcomes. Earlier age of smoking onset and oral only smoke intake (as opposed to lung inhalation) were also linked to greater mortality risk. Smoking was an independent risk factor for COPD-specific, CVD and all-cause mortality in COPD patients from Sichuan with higher tobacco consumption giving a stronger association.
Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.
Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.
Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.